Reich Samuel J
Insider CIK 1394645 · BCYP Executive Chairman, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2026-02-03 | 2026-02-05 | 4,800,000 | — | $0 | 4,800,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2025-08-26 | 2025-08-28 | 4,800,000 | — | $0 | 4,800,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2024-07-15 | 2024-07-17 | 35,700 | — | $0 | 35,700 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2024-02-21 | 2024-02-23 | 434,000 | — | $0 | 434,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | P Buy | 2023-11-29 | 2023-11-30 | 11,000 | $0.89 | $9.8K | 219,001 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-03-14 | 2023-03-16 | 525,000 | — | $0 | 525,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | J Other deriv | 2023-02-28 | 2023-03-02 | 9,968 | — | $0 | 9,968 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | J Other deriv | 2023-02-28 | 2023-03-02 | 208,600 | — | $0 | 0 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2022-09-13 | 2022-09-15 | 525,000 | — | $0 | 525,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | J Other | 2022-05-20 | 2022-05-23 | 2,500,127 | — | $0 | 547,698 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | J Other | 2022-05-20 | 2022-05-23 | 207,001 | — | $0 | 208,001 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2022-03-16 | 2022-03-18 | 7,000 | — | $0 | 7,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2021-11-17 | 2021-11-19 | 350,000 | — | $0 | 350,000 | SEC↗ |
| BCYP Big Cypress Acquisition Co | P Buy | 2021-10-14 | 2021-10-15 | 1,000 | $10.11 | $10.1K | 1,000 | SEC↗ |
| BCYP Big Cypress Acquisition Co | P Buy | 2021-01-14 | 2021-01-14 | 417,200 | $10.00 | $4.17M | 3,047,825 | SEC↗ |